MA46888A - Inhibiteurs de gsk-3 - Google Patents
Inhibiteurs de gsk-3Info
- Publication number
- MA46888A MA46888A MA046888A MA46888A MA46888A MA 46888 A MA46888 A MA 46888A MA 046888 A MA046888 A MA 046888A MA 46888 A MA46888 A MA 46888A MA 46888 A MA46888 A MA 46888A
- Authority
- MA
- Morocco
- Prior art keywords
- gsk
- inhibitors
- Prior art date
Links
- 102000002254 Glycogen Synthase Kinase 3 Human genes 0.000 title 1
- 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662426630P | 2016-11-28 | 2016-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46888A true MA46888A (fr) | 2021-06-02 |
Family
ID=60655129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046888A MA46888A (fr) | 2016-11-28 | 2017-11-27 | Inhibiteurs de gsk-3 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10774086B2 (https=) |
| EP (1) | EP3544980B1 (https=) |
| JP (1) | JP6977038B2 (https=) |
| KR (1) | KR102611539B1 (https=) |
| CN (1) | CN110225912B (https=) |
| ES (1) | ES2896938T3 (https=) |
| MA (1) | MA46888A (https=) |
| WO (1) | WO2018098411A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3920885A1 (en) | 2019-02-08 | 2021-12-15 | Frequency Therapeutics, Inc. | Valproic acid compounds and wnt agonists for treating ear disorders |
| CN111620881B (zh) * | 2020-07-08 | 2023-03-31 | 浙江合聚生物医药有限公司 | 拉罗替尼衍生物及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY29823A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones |
| US20090170847A1 (en) * | 2006-01-23 | 2009-07-02 | Seung Chul Lee | Imidazopyridine Derivatives Inhibiting Protein Kinase Activity, Method for the Preparation Thereof and Pharmaceutical Composition Containing Same |
| US20100292205A1 (en) * | 2006-08-23 | 2010-11-18 | Pfizer Inc. | Pyrimidone Compounds As GSK-3 Inhibitors |
| US8053574B2 (en) * | 2007-07-18 | 2011-11-08 | Novartis Ag | Organic compounds |
| SI2694510T1 (sl) * | 2011-04-07 | 2016-02-29 | Bayer Intellectual Property Gmbh | Imidazopiridazini kot inhibitorji AKT kinaze |
| RU2014120180A (ru) * | 2011-10-20 | 2015-11-27 | ГЛЭКСОСМИТКЛАЙН ЭлЭлСи | Замещенные бициклические аза-гетероциклы и аналоги в качестве модуляторов сиртуина |
| CN105849098A (zh) * | 2013-11-06 | 2016-08-10 | 百时美施贵宝公司 | Gsk-3抑制剂 |
-
2017
- 2017-11-27 CN CN201780084338.1A patent/CN110225912B/zh active Active
- 2017-11-27 EP EP17812187.7A patent/EP3544980B1/en active Active
- 2017-11-27 WO PCT/US2017/063230 patent/WO2018098411A1/en not_active Ceased
- 2017-11-27 JP JP2019528536A patent/JP6977038B2/ja active Active
- 2017-11-27 KR KR1020197018281A patent/KR102611539B1/ko active Active
- 2017-11-27 US US16/463,451 patent/US10774086B2/en active Active
- 2017-11-27 MA MA046888A patent/MA46888A/fr unknown
- 2017-11-27 ES ES17812187T patent/ES2896938T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019535790A (ja) | 2019-12-12 |
| KR20190085112A (ko) | 2019-07-17 |
| EP3544980A1 (en) | 2019-10-02 |
| US20190276463A1 (en) | 2019-09-12 |
| EP3544980B1 (en) | 2021-10-13 |
| ES2896938T3 (es) | 2022-02-28 |
| CN110225912B (zh) | 2022-10-21 |
| US10774086B2 (en) | 2020-09-15 |
| CN110225912A (zh) | 2019-09-10 |
| KR102611539B1 (ko) | 2023-12-06 |
| JP6977038B2 (ja) | 2021-12-08 |
| WO2018098411A1 (en) | 2018-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263586A (en) | Inhibitors of the menin-mll interaction | |
| IL269196A (en) | Novel inhibitors | |
| EP3541932A4 (en) | INHIBITORS OF CRISPR-CAS9 | |
| DK3497103T3 (da) | Pyridopyrimdinon-cdk2/4/6-inhibitorer | |
| DK3442972T3 (da) | Bromdomænehæmmere | |
| LT3303334T (lt) | Tirozinkinazės inhibitoriai | |
| EP3440949A4 (en) | FLAVOR INHALER | |
| DK3571192T3 (da) | Jak1-selektive inhibitorer | |
| EP3347008A4 (en) | BETA-Lactamase INHIBITORS | |
| HUE042335T2 (hu) | ROR-gamma dihidropirrolopiridin inhibitorai | |
| CU20160125A7 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| MA53944A (fr) | Inhibiteurs de la glycosidase | |
| EP3313828A4 (en) | METALLO-BETA-Lactamase INHIBITORS | |
| EP3541820A4 (en) | MAGL INHIBITORS | |
| MA46857A (fr) | Inhibiteurs de magl | |
| EP3541822A4 (en) | MAGL INHIBITORS | |
| DK3335532T3 (da) | Tandharve | |
| DK3186242T3 (da) | Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere | |
| DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
| MA46889A (fr) | Inhibiteurs de gsk-3 | |
| MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
| DK3114120T3 (da) | Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere | |
| MA46280A (fr) | Inhibiteurs de la dopamine-b-hydroxylase | |
| EP3600301A4 (en) | KDM4 INHIBITORS | |
| DK3481826T3 (da) | Tyrosinkinaseinhibitorer |